Webinar: Accelerating RIM System Compliance with AI and Sporify
Seamlessly deploy the latest innovations and recognize immediate value.
Webinar: The Rise of Agentic PV: AI that thinks, plans, and acts
Learn how Agentic AI is bringing a new era of innovation to pharmacovigilance.
On June 5th, 2019, ArisGlobal held a webinar focused on the “Key Use Cases of Automation in Pharmacovigilance.” During that event, 84% of attendees indicated a significant increase in their case volumes over the last five years. Only 15% considered their case volume increases to be ‘slight.’
As the outsourcing trend continues to grow, many biopharmaceutical and ...
Your team’s workload grows by the day. The volume of Safety cases you’re ...
South Korean Contract Research Organization, LSK, spoke in a webinar ...
The ArisGlobal marketing department spent time with Clint Wolfe, Chief Human Resources Officer. They discussed changes at ArisGlobal, working from home, how different areas of the globe are handling COVID-19 differently, and more.
There has been significant changes in the way the EMA expects MAHs to handle ICSRs from the new EudraVigilance system, creating additional work for already busy pharmacovigilance departments
Safety is evolving rapidly. There is a major, emerging opportunity ...
Safety departments at Marketing Authorization Holders & Regulatory Authorities are ...
As different regulatory authorities have different timelines for adoption of these standards, E2B(R2) E2B(R3) will have to coexist. But having to operate two solutions creates huge complexities, unless you find a solution compliant with both. ArisGlobal LifeSphere Safety MultiVigilance is the only drug safety database solution provider thus far to provide full compliance to E2B R2 and E2B R3 standards for both import and export.
LifeSphere Safety MultiVigilance (LSSMV) database system has auto-translation capabilities that can translate safety narratives from English to Chinese and vice versa using advanced machine-learning technology.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved